Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining 0.27% today. In the last week its performance is -0.09%, and 13.44% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 35.5, so today’s gain of 0.27% is a significant step towards its target price. The GAP today is therefore -0.06%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 170576.39, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 12.20%.
At the current price of 33.18, it has a dividend yield of 2.71%, and its target price is 35.5. This is with a profit margin of 9.20%, and total debt/equity of 1.3. AstraZeneca PLC (NYSE:AZN) has a P/E of 37.79, as well as a forward P/E of 12.38.
With a current EPS of 0.88, and a forecasted EPS growth for next year at -9.76%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -16.70%. For the next five years EPS growth is projected to be -1.00%.
Performance for the year is 5.41%. Since its IPO date on 5/17/1993, the total performance to date is 2.24%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 4478800, while its average volume is 6207.67. Whilst the total gain today was 0.27%, it did have a day high of -4.04%.
Volatility for this week has been at 0.97%, and 1.13% for the month. The 52-week low for AstraZeneca PLC, AZN has been 24.67%, while the 52-week-high has reached -4.04%.
Looking at its return of investments, which is 11.50%, and its return on assets is 3.70%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 15.00%. With a sales growth of -11.20% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 1.22, and has a current ratio of 0.9 and 0.8 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is *TBA, and the P/S is 7.09, along with a P/B of 6.2. Meanwhile it has a p/cash of 36.71.